-
公开(公告)号:EP2862577B1
公开(公告)日:2017-08-02
申请号:EP13761384.0
申请日:2013-03-08
CPC分类号: C07K14/575 , A61K38/2214 , C07K14/60
-
2.
公开(公告)号:EP2862577A1
公开(公告)日:2015-04-22
申请号:EP13761384.0
申请日:2013-03-08
CPC分类号: C07K14/575 , A61K38/2214 , C07K14/60
摘要: The present invention relates to the use of obestatin, or to the nucleotide sequence that codes for same, as an in vitro myogenic agent, and for the production of a drug for muscle regeneration, preferably for musculoskeletal regeneration, thus being useful in the treatment and/or prevention of degenerative or genetic diseases or of lesions that present with muscle damage.
摘要翻译: 本发明涉及肥胖抑制剂,或编码与体外成肌剂相同的核苷酸序列的用途,以及用于生产用于肌肉再生的药物,优选用于肌肉骨骼再生,因此可用于治疗和 /或预防退行性或遗传性疾病或伴有肌肉损伤的病变。
-
公开(公告)号:EP4434579A1
公开(公告)日:2024-09-25
申请号:EP23382269.1
申请日:2023-03-23
申请人: Servizo Galego de Saude , Fundación Instituto de Investigación Sanitaria de Santiago de Compostela (FIDIS) , Universidade de Santiago de Compostela
发明人: PAZOS RANDULFE, Yolanda , PÉREZ CAMIÑA, Jesús , DOMÍNGUEZ MUÑOZ, Juan Enrique , CID DÍAZ, Tania , SANTOS ZÁS, Icía , LEAL LÓPEZ, Saúl , CALVIÑO LODEIRO, Andrea
CPC分类号: A61K38/25 , C07K14/60 , A61P5/48 , C07K14/4702 , C12N9/12 , C12Y207/11024
摘要: Obestatin for use as antineoplastic agent in the treatment of pancreatic cancer. The present invention refers to the use obestatin as antineoplastic agent in the treatment of pancreatic cancer.
-
-